Sundar Jagannath, MD, Director of the Multiple Myeloma Program and Professor of Medicine at Mt. Sinai, is the principal investigator behind FDA accelerated approval of Xpovio (selinexor) for multiple myeloma. Sundar Jagannath, MD, was the principal investigator of the...